NCT02153372已完成1 期
Cell Based Therapy by Implanted Bone Marrow-derived Mononuclear Cells (BMC) for Bone Augmentation of Plate-stabilized Proximal Humeral Fractures
Goethe University2 个研究点 分布在 1 个国家目标入组 10 人开始时间: 2013年7月1日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- 入组人数
- 10
- 试验地点
- 2
- 主要终点
- safety
研究概览
简要总结
In the present phase-I clinical trial we investigate safety and feasibility of an augmentation with preoperatively isolated autologous BMC cells seeded onto ß-TCP in combination with an angle stable fixation (Philos plate®) for the therapy of proximal humeral fractures.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 50 Years 至 90 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •patients aged between
- •years with proximal humerus fractures
- •indication for open reposition and internal stabilisation with a proximal fixed- angle plate for humerus (PHILOS, Synthes, Oberdorf, Swiss):
- •2-, 3- or 4-fragment fracture according to NEer
- •dislocation of >10 mm between fragments and/or
- •angle of > 45° between fragments and/or
- •dislocation of tuberculum major > 5 mm
- •negative pregnancy test of premenopausal women
- •signed informed consent for surgery and participation in the clinical trial
排除标准
- •contraindications against administration of Investigational medicinal product (IMP) is pregnancy and nursing
- •dislocation fracture
- •known psychic disorder that leads to incompliance (e.g. dementia, schizophrenia, major depression)
- •pathologic fractures caused by other underlying diseases
- •fracture-induced nerve damage
- •tumor disease with recent adjuvant therapy or treatment during the last 3 months (e.g. chemotherapy, radiotherapy), untreated tumor diseases
- •known hypersensibility against components of the transplant
- •participation in a clinical trial during the last 3 months prior to this study
结局指标
主要结局
safety
时间窗: week 12 post surgery
Analysis of safety : morbidity of bone marrow punction local reaction (infection, delayed wound healing) systemic reaction (leucocytes, C-reactive protein, Interleukin-6, procalcitonin) fever (\> 38,5°C longer than 2 days)
次要结局
- feasibility(week 12 post surgery)
研究者
Ingo Marzi, MD Prof.
head physician
Goethe University
研究点 (2)
Loading locations...
相似试验
已完成
2 期
Cell Therapy by Autologous BMC for Large Bone Defect RepairHumerus Fracture Displaced ProximalNCT02803177Goethe University55
Unknown
1 期
Autologous Bone Marrow Mononuclear Cells in Liver CirrhosisLiver Cirrhosis Due to Virus C Chronic HepatitisNCT00832247Universidade Federal do Rio de Janeiro15
终止
1 期
Safety Study of Autologous Stem Cell in Liver CirrhosisLiver CirrhosisNCT00382278Universidade Federal do Rio de Janeiro15
Unknown
1 期
Mesenchymal Stem Cells Transplantation to Patients With Relapsed/Refractory Aplastic Anemia.Aplastic AnemiaNCT01305694Guangzhou General Hospital of Guangzhou Military Command50
暂停
1 期
Transfer of Bone Marrow Derived Stem Cells for the Treatment of Spinal Cord InjurySpinal Cord InjuryNCT01162915TCA Cellular Therapy10